Biopharma Daily Stock Updates - 03/23/22

$XBI $89.86 | -2.55%

---

Covid Updates

$MRNA -4.3% Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint. source

Pipeline Updates

$LBPS +28.5% 4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab) for the Treatment of Renal Cell Carcinoma. source

Business Updates

$

---

Posted by FS/JM